Subscribe To
Mesoblast's (meso) gvhd drug bla gets fda priority tag, stock up
Mesoblast (MESO) announces the FDA acceptance for review of the resubmitted biological license applicat...
March 9, 2023, 8:24 am
Imv inc. to announce fourth quarter and fiscal year 2022 results and host a conference call and webcast on march 16, 2023
DARTMOUTH, Nova Scotia & CAMBRIDGE, Mass.--(BUSINESS WIRE)---- $IMV #CancerVaccine--IMV Inc. (NASDAQ: IMV; TSX: IMV), a clinical-stage company develop...
March 9, 2023, 7:05 am
Tendonova inks partnership with accellerated biologics
ATLANTA, March 08, 2023 (GLOBE NEWSWIRE) — TendoNova, an emerging leader in micro-invasive sports medicine procedures, is pleased to announce that i...
March 8, 2023, 2:25 pm
Tiziana life sciences hails publication in science journal of article on mechanism of action for intranasal foralumab
Tiziana Life Sciences Ltd (NASDAQ:TLSA) has announced a publication in the preeminent journal Proceedings of the National Academy of Sciences (PNAS) ...
March 8, 2023, 8:05 am
Zalando the 'clear market leader,' says deutsche bank
Zalando is the “clear market leader” in online European apparel, according to Deutsche Bank, despite profits reaching a four-year low. Analysts at...
March 8, 2023, 6:14 am
Eur/gbp price analysis: buyers moved in and lifted the exchange rate above 0.8900, eyeing 0.9000
EUR/GBP climbed above 0.8900 and a one-month-old downslope trendline. EUR/GBP Price Analysis: Upward biased, at the brisk of cracking 0.9000. The EUR/...
March 7, 2023, 10:59 pm
Myomo to report fourth quarter financial results on march 13, 2023
BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increase...
March 7, 2023, 10:12 am
Magnitude 6 earthquake strikes mindanao, philippines -emsc
(Reuters) – A magnitude 6.0 earthquake struck Mindanao in the Philippines on Tuesday, the European Mediterranean Seismo...
March 7, 2023, 6:36 am
Dupixent® (dupilumab) application for treatment of chronic spontaneous urticaria (csu) in adults and adolescents aged 12 years and older accepted for fda review
More than 300,000 people in the U.S. suffer from CSU that is inadequately controlled by antihistamines TARRYTOWN, N.Y. and PARIS, March 07, 2023 (GLOB...
March 7, 2023, 6:00 am
Chile announces biological corridor to protect endangered deer
SANTIAGO (Reuters) – Chile launched a program on Monday to protect the huemul, an endangered southern deer, by creating a bio...
March 6, 2023, 10:06 pm
Avid bioservices to report financial results for third quarter of fiscal year 2023 after market close on march 13, 2023
TUSTIN, Calif., March 06, 2023 (GLOBE NEWSWIRE) — Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologic...
March 6, 2023, 9:05 pm
Why shares of anavex life sciences rose 12.4% in february
Anavex is a clinical-stage biotech stock with no revenue. The company's lead therapy is being tested to treat a host of neurodegenerative and neuro
March 6, 2023, 8:21 pm
Neuroendoscopy devices market predicted to garner usd 326 million by 2032, at cagr 5.30% | market.us
According to Market.us, global neuroendoscopy devices market size is projected to surpass around USD 326 million by 2032, and it is anticipated to reg...
March 6, 2023, 6:46 pm
Wish to participate in loop capital markets 2023 virtual investor conference
SAN FRANCISCO, March 06, 2023 (GLOBE NEWSWIRE) -- Contextlogic Inc. (d/b/a Wish) (NASDAQ: WISH), one of...
March 6, 2023, 6:05 pm
Nurix therapeutics to present at the oppenheimer 33rd annual healthcare conference
SAN FRANCISCO, March 06, 2023 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company developing targe...
March 6, 2023, 4:01 pm
How cirrus logic stock gained 13.7% last month
Surprisingly strong demand for smartphones, particularly from Apple's iPhone, helped lift Cirrus' business above guidance. Cirrus is pumping the brake...
March 6, 2023, 1:09 pm
Ocugen appoints quan a. vu to chief financial officer & chief business officer
MALVERN, Pa., March 06, 2023 (GLOBE NEWSWIRE) — Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering,...
March 6, 2023, 12:02 pm
Biologics market economic growth cagr of 9.1%, restraints, mergers and forecast (2022-2032)
The biologics market is projected to surpass USD 893 billion by 2032, and it is poised to reach a CAGR ...
March 6, 2023, 6:16 am
Fda accepts eisai’s filing of a supplemental biologics license application and grants priority review for traditional approval of leqembi™ (lecanemab-irmb) for the treatment of alzheimer’s disease
Confirmatory Phase 3 Clarity AD data to be evaluated by FDA in determining whether to convert accelerated approval of LEQEMBI to a traditional approva...
March 5, 2023, 11:30 pm
7 high-growth stocks for esg-oriented investors
Generally, a perception exists that supporting environmental, social, and governance ( ESG ) initiatives may lead to expansion and profitability erosi...
March 5, 2023, 11:19 am